Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04916249

Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors

Tibetree Pain-Relieving Plaster for Musculoskeletal Pain Among Cancer Survivors

Status
Active Not Recruiting
Phase
Phase 2
Study type
Interventional
Enrollment
68 (actual)
Sponsor
Memorial Sloan Kettering Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to find out whether Tibetree Pain Relieving Plaster, an herbal pain relief patch, may be able to reduce this pain. Tibetree Pain Relieving Plaster is available as an over-the-counter (non-prescription) treatment for the temporary relief of minor aches and pains in muscles and joints. This study is the first to test this treatment in people who have had cancer.

Conditions

Interventions

TypeNameDescription
DRUGTibetree Pain Relieving PlasterParticipants who provide informed consent in the trial will receive either the Tibetree pain relieving plaster if randomized into the intervention arm, or an identical placebo plaster if randomized into the control arm. The treatment course for both arms are identical. Participants will be instructed to apply the plaster directly to the skin overlying the area of pain for 6 hours once daily for 14 consecutive days.
OTHERPlaceboParticipants who provide informed consent in the trial will receive either the Tibetree pain relieving plaster if randomized into the intervention arm, or an identical placebo plaster if randomized into the control arm. The treatment course for both arms are identical. Participants will be instructed to apply the plaster directly to the skin overlying the area of pain for 6 hours once daily for 14 consecutive days.

Timeline

Start date
2021-05-28
Primary completion
2026-05-28
Completion
2026-05-28
First posted
2021-06-07
Last updated
2025-06-17

Locations

7 sites across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT04916249. Inclusion in this directory is not an endorsement.